If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:128270-60-0
Source:Taiwan
Qualifications:USDMF/-/-/-/-
| Name | Bivalrudine |
|---|---|
| Chinese name | 比伐芦定 |
| Cas Number | 128270-60-0 |
| Source | Taiwan |
| Qualifications | USDMF/-/-/-/- |
The development company is The Medicines Company, which was approved by the FDA in December 2000 and approved by the EMA in September 2004. Bivarudine is a specific and reversible direct thrombin inhibitor, by inhibiting thrombin in the blood and blood clots, preventing thrombin-induced platelet activation and aggregation to achieve anticoagulation. It is usually used for unstable angina pectoris in the treatment of percutaneous transluminal coronary angioplasty and heparin-induced thrombocytopenia or heparin-induced thrombocytopenia and thrombosis syndrome in percutaneous coronary intervention therapy, and at the same time Temporary replacement of glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention. The same target drugs include dabigatran etexilate mesylate and argatroban. Bivarudine is recommended by PCI-related guidelines and has a good clinical prospect.
Hot Tags: bivalrudine api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Temozolomide API, Gabapentin API, Idebenone API, Deoxycholic Acid API, Pabxilib API, Lifitegrast API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
